101-22-4

Basic information

• Product Name: Urea, N,N'-bis(3-aminophenyl)-
• Synonyms: N,N'-bis(3-aminophenyl)urea
• CAS NO: 101-22-4
• Molecular Formula: C₁₃H₁₄N₄O
• Molecular Weight: 242.27646
• Mol File: 101-22-4.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Urea, N,N'-bis(3-aminophenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Urea, N,N'-bis(3-aminophenyl)-(101-22-4)
• EPA Substance Registry System: Urea, N,N'-bis(3-aminophenyl)-(101-22-4)

Safety Data

• Hazardous Substances Data: 101-22-4(Hazardous Substances Data)

Usage

General Description

Urea, N,N'-bis(3-aminophenyl)-, is a chemical compound with a molecular structure characterized by two 3-aminophenyl groups linked by a urea bridge. It holds significance in the field of organic chemistry and materials science, serving as a building block for the synthesis of various organic molecules and polymers. The presence of amino groups on the phenyl rings enhances its reactivity and makes it valuable in the creation of functionalized compounds with diverse applications, including pharmaceuticals, dyes, and specialty chemicals. Its ability to participate in versatile chemical reactions allows for the design and development of complex molecules with tailored properties, contributing to advancements in various industrial and scientific disciplines.

Upstream product

• 3320-87-4 isocyanic acid (3-nitro-phenyl) ester 
• 99-09-2 3-nitro-aniline 
• 1234-21-5 1,3-bis(3-nitrophenyl)urea 

Downstream Products

• 92-62-6 proflavine 
• 1279692-22-6 1,3-bis(3-{[(2-methylphenyl)carbamoyl]amino}phenyl)urea 
• 1160839-62-2 N,N'-bis(3-(3-nitrobenzamido)phenyl)urea 
• 96615-82-6 1,3-Bis-[3-(4,6-diamino-2,2-dimethyl-2H-[1,3,5]triazin-1-yl)-phenyl]-urea; hydrochloride 
• 53357-12-3 1,3-Bis-(3-amino-4-thiocyanato-phenyl)-urea 

Relevant articles and documents

Discovery of the first small molecule inhibitor of human DDX3 specifically designed to target the RNA binding site: Towards the next generation HIV-1 inhibitors

Efficacy of currently approved anti-HIV drugs is hampered by mutations of the viral enzymes, leading invariably to drug resistance and chemotherapy failure. Recent data suggest that cellular co-factors also represent useful targets for anti-HIV therapy. H

An 'inside-out' approach to suramin analogues

An approach to the synthesis of suramin analogues has been realised, which avoids synthetic problems associated with conventional routes. The use of isobutyl ester protecting groups for sulfonic acids was crucial to the success of the strategy, because these were able to be cleanly deprotected with sodium iodide, yielding the sodium salts of the corresponding sulfonic acids.